Integrative Exploring the intersection between traditional ayahuasca healing and allopathic medicine.
01:05:06 min
CLEAR ALL
Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often-confusing relationship with psychoactive substances.
2
In 2014, former British Para Keith Abraham flew to Peru to see if he could cure his post-traumatic stress disorder with a dose of the psychedelic drug, ayahuasca. He returned a changed man and is now on a mission to extend access to other members of the armed forces and beyond
1
In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.
A new study finds widespread exclusion of minorities in psychedelic research.
We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Research over the last decade has shown MDMA-assisted psychotherapy to be effective in treating PTSD from military combat, sexual assault and childhood abuse. Now researchers are trialing MDMA with couples and finding promising results.
Despite modern pharmaceutical medications and many different psychological therapies, military veterans and survivors of mental and physical trauma from civil society continue to suffer from post-traumatic stress disorder (PTSD).